Prevention of schizophrenia

References

• Tsuang MT, Stone WS, Faraone SV. Schizophrenia: a review of genetic studies. Harv. Rev. Psychiatry7, 185–207 (1999).
   PubMed Web of Science ®Google Scholar
• Hu TW. Perspectives: an international review of the national cost estimates of mental illness, 1990–2003. J. Ment. Health Policy Econ.9, 3–13 (2006).
   PubMed Web of Science ®Google Scholar
• Wu EQ, Birnbaum HG, Shi L et al. The economic burden of schizophrenia in the United States in 2002. J. Clin. Psychiatry66, 1122–1129 (2005).
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Stone WS, Faraone SV. Towards reformulating the diagnosis of schizophrenia. Am. J. Psychiatry147, 1041–1050 (2000).
   Google Scholar
• Braff DL, Freedman R, Schork NJ, Gottesman II. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr. Bull.33, 21–32 (2007).
   PubMed Web of Science ®Google Scholar
• Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry160, 636–645 (2003).
   PubMed Web of Science ®Google Scholar
• Bilder RM. Phenomics: building scaffolds for biological hypotheses in the post-genomic era. Biol Psychiatry63(5), 439–440 (2008).
   PubMed Web of Science ®Google Scholar
• Bassett AS, Marshall CR, Lionel AC, Chow EW, Scherer SW. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum. Mol. Genet.17(24), 4045–4053 (2008).
   PubMed Web of Science ®Google Scholar
• Bassett AS, Chow EW. Schizophrenia and 22q11.2 deletion syndrome. Curr. Psychiatry Rep.10(2), 148–157 (2008).
   PubMedGoogle Scholar
• Greenwood TA, Braff DL, Cadenhead KS et al. The Consortium on the Genetics of Schizophrenia (COGS): preliminary heritability analyses of endophenotypic measures for schizophrenia. Arch. Gen. Psychiatry64, 1242–1250 (2007).
   PubMed Web of Science ®Google Scholar
• Manschreck TC, Boshes RA. The CATIE schizophrenia trial: results, impact, controversy. Harv. Rev. Psychiatry15, 245–258 (2009).
   Web of Science ®Google Scholar
• Carpenter WT, Gold JM. Another view of therapy for cognition in schizophrenia. Biol. Psychiatry52, 969–971 (2002).
   Google Scholar
• Keefe RSE, Bilder RM, Davis SM et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch. Gen. Psychiatry64, 633–647 (2007).
   PubMed Web of Science ®Google Scholar
• Swartz MS, Perkins DO, Stroup TS et al. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Am. J. Psychiatry164, 428–436 (2007).
   PubMed Web of Science ®Google Scholar
• Yung AR, Killackey E, Hetrick SE et al. The prevention of schizophrenia. Int. Rev. Psychiatry19(6), 633–646 (2007).
   PubMed Web of Science ®Google Scholar
• Gottesman II, Hanson DR. Human development: biological and genetic processes. Annu. Rev. Psychol.56, 263–286 (2005).
   PubMed Web of Science ®Google Scholar
• Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol. Med.33(1), 97–110 (2003).
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Amirsadri A. Early intervention in schizophrenia: current and future perspectives. Curr. Psychiatry Rep.9(4), 325–328 (2007).
   PubMedGoogle Scholar
• Cornblatt BA, Lencz T, Smith C, Auther A. Treatment of the schizophrenia prodrome. In: Recognition and Prevention of Major Mental and Substance Abuse Disorders. Tsuang MT, Stone WS, Lyons MJ (Eds). American Psychiatric Publishing, Inc., DC, USA, 159–185 (2007).
   Google Scholar
• Cornblatt B, Lencz T, Obuchowski M. The schizophrenia prodrome: treatment and high-risk perspectives. Schizophr. Res.54(1–2), 177–186 (2002).
   PubMed Web of Science ®Google Scholar
• Brown KW, White T. Syndromes of chronic schizophrenia and some clinical correlates. Br. J. Psychiatry161, 317–322 (1992).
   PubMed Web of Science ®Google Scholar
• Brown AS, Susser ES. Prenatal nutritional deficiency and risk of adult schizophrenia. Schizoph. Bull.1054–1063 (2008).
   PubMed Web of Science ®Google Scholar
• Kinney DK, Teixeira P, Hsu D et al. Relation of schizophrenia to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections? Schizophr. Bull.35, 582–595 (2009).
   PubMed Web of Science ®Google Scholar
• Glatt SJ, Faraone SV, Tsuang MT. Genetic risk factors for mental disorders: General principles and state of the science. In: Recognition and Prevention of Major Mental and Substance Use Disorders. Tsuang MT, Stone WS, Lyons MJ (Eds). American Psychiatric Publishing, Inc., DC, USA, 3–20 (2007).
   Google Scholar
• Tsuang MT, Stone WS, Johnston JM. Gene–environment interactions in mental disorders: a current view. In: The Impact of the Environment on Psychiatric Disorder. Freeman H, Stansfeld S (Eds). Routledge, London, UK, 27–51 (2008).
   Google Scholar
• Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O. Effects of family history and place and season of birth on the risk of schizophrenia. N. Eng. J. Med.340, 603–608 (1999).
   PubMed Web of Science ®Google Scholar
• Mortensen PB, Pedersen MG, Pedersen CB. Psychiatric family history and schizophrenia risk in Denmark: which mental disorders are relevant? Psychol. Med.40, 201–210 (2010).
   PubMed Web of Science ®Google Scholar
• Dazzan P, Kravariti E, Fearon P, Murray RM. Is the development of schizophrenia predictable? In: Early Clinical Intervention and Prevention in Schizophrenia. Stone WS, Faraone SV, Tsuang MT (Eds). Humana Press, NJ, USA, 225–252 (2004).
   Google Scholar
• Stone WS, Faraone SV, Seidman LJ, Olson EA, Tsuang MT. Searching for the liability to schizophrenia: concepts and methods underlying genetic high-risk studies of adolescents. J. Child Adolesc. Psychopharmacol.15, 403–417 (2005).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Doyle A. The nature and heritability of attention deficit hyperactivity disorder. Child Adolesc. Psychiatr. Clin. N. Am.10, 299–316 (2001).
   PubMed Web of Science ®Google Scholar
• Hans SL, Auerbach JG, Auerbach AG, Marcus J. Development from birth to adolescence of children at-risk for schizophrenia. J. Child Adolesc. Psychopharmacol.15(3), 384–394 (2005).
   PubMed Web of Science ®Google Scholar
• Hans SL, Auerbach JG, Asarnow JR, Styr B, Marcus J. Social adjustment of adolescents at risk for schizophrenia: the Jerusalem infant development study. J. Am. Acad. Child Adolesc. Psychiatry39(11), 1406–1414 (2000).
   PubMed Web of Science ®Google Scholar
• Walker E, Lewine RJ. Prediction of adult-onset schizophrenia from childhood home movies of the parents. Am. J. Psychiatry147(8), 1052–1056 (1990).
   PubMed Web of Science ®Google Scholar
• Schiffman J, Walker E, Ekstrom M, Schulsinger F, Sorensen H, Mednick S. Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. Am. J. Psychiatry161, 2021–2027 (2004).
   PubMed Web of Science ®Google Scholar
• Eack SM, Mermon DE, Montrose DM et al. Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr. Bull. DOI: 10.1093/schbul/sbp026 (2010) (Epub ahead of print).
   Google Scholar
• Siira V, Wahlberg KE, Miettunen J, Tienari P, Laksy K. Differentiation of adoptees at high versus low genetic risk for schizophrenia by adjusted MMPI indices. Eur. Psychiatry21(4), 245–250 (2006).
   PubMed Web of Science ®Google Scholar
• Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr. Bull.33(1), 69–94 (2007).
   PubMed Web of Science ®Google Scholar
• Takahashi S, Tanabe E, Yara K, Matsuura M, Matsushima E, Kojima T. Impairment of exploratory eye movement in schizophrenia patients and their siblings. Psychiatry Clin. Neurosci.62(5), 487–493 (2008).
   PubMed Web of Science ®Google Scholar
• Calkins ME, Iacono WG, Curtis CE. Smooth pursuit and antisaccade performance evidence trait stability in schizophrenia patients and their relatives. Int. J. Psychophysiol.49(2), 139–146 (2003).
   PubMed Web of Science ®Google Scholar
• Calkins ME, Iacono WG, Ones DS. Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes. Brain Cogn.68(3), 436–461 (2008).
   PubMed Web of Science ®Google Scholar
• Cannon TD. Abnormalities of brain structure and function in schizophrenia: implications for etiology and pathophysiology. Ann. Med.28, 533–539 (1996).
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Pantelis C, Keshavan MS et al. A review and a new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a MRI morphometric family study of the parahippocampal gyrus. Schizophr. Bull.29, 803–808 (2003).
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Montrose DM, Pierri JN et al. Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies. Prog. Neuropsychopharmacol. Biol. Psychiatry21, 1285–1295 (1997).
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Dick E, Mankowski I et al. Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. Schizophr. Res.58, 173–183 (2002).
   PubMed Web of Science ®Google Scholar
• MacDonald AW 3rd, Thermenos HW, Barch DM, Seidman LJ. Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients’ nonpsychotic relatives. Schizophr. Bull.35(6), 1142–1162 (2009).
   PubMed Web of Science ®Google Scholar
• Munoz Maniega S, Lymer GK, Bastin ME et al. A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia. Schizophr. Res.106(2–3), 132–139 (2008).
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Dick RM, Diwadkar VA, Montrose DM, Prasad KM, Stanley JA. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a 1H spectroscopy study. Schizophr. Res.115(1), 88–93 (2009).
   PubMed Web of Science ®Google Scholar
• Modrego PJ. Depression in the prodromal phase of Alzheimer disease and the reverse causal hypothesis. Arch. Gen. Psychiatry66(1), 107 (2009).
   PubMed Web of Science ®Google Scholar
• Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: a meta-analysis. Br. J. Psychiatry167(6), 786–793 (1995).
   PubMed Web of Science ®Google Scholar
• Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry159(7), 1080–1092 (2002).
   PubMed Web of Science ®Google Scholar
• McGrath JJ. Gaining traction on the epidemiologic landscape of schizophrenia. Am. J. Epidemiol.158, 301–304 (2003).
   PubMed Web of Science ®Google Scholar
• Gilbert AR, Montrose DM, Sahni SD, Diwadkar VA, Keshavan MS. Obstetric complications correlate with neurobehavioral and brain structural alterations in young relatives at risk for schizophrenia. Ann. NY Acad. Sci.1008, 269–275 (2003).
   PubMed Web of Science ®Google Scholar
• Gur RE, Calkins ME, Gur RC et al. The Consortium on the Genetics of Schizophrenia (COGS): neurocognitive endophenotypes. Schizophr. Bull.33, 49–68 (2007).
   PubMed Web of Science ®Google Scholar
• Kremen WS, Hoff AL. Neurocognitive deficits in the biological relatives of individuals with schizophrenia. In: Early Clinical Intervention and Prevention with Schizophrenia. Stone WS, Faraone SV, Tsuang MT (Eds). Humana Press, NJ, USA, 133–158 (2004).
   Google Scholar
• Snitz BE, MacDonald III AW, Carter AS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr. Bull.32, 179–194 (2006).
   PubMed Web of Science ®Google Scholar
• Prasad KM, Sanders R, Sweeney J et al. Neurological abnormalities among offspring of persons with schizophrenia: relation to premorbid psychopathology. Schizophr. Res.108(1–3), 163–169 (2009).
   PubMed Web of Science ®Google Scholar
• Kremen WS, Seidman LJ, Goldstein JM, Faraone SV, Tsuang MT. Systematized delusions and neuropsychological function in paranoid and nonparanoid schizophrenia. Schizophr. Res.12, 223–236 (1994).
   PubMed Web of Science ®Google Scholar
• Brewer WJ, Wood SJ, Phillips LJ et al. Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr. Bull.32, 538–555 (2006).
   PubMed Web of Science ®Google Scholar
• Stone WS, Faraone SV, Seidman LJ, Olson EA, Tsuang MT. Searching for the liability to schizophrenia: concepts and methods underlying genetic high-risk studies of adolescents. J. Child Adolesc. Psychopharmacol.15(3), 403–417 (2005).
   PubMed Web of Science ®Google Scholar
• Hill SK, Reilly JL, Harris MSH et al. A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder and schizophrenia. Schizophr. Res.113, 167–175 (2009).
   PubMed Web of Science ®Google Scholar
• Asarnow RF, Neuchterlein KH, Subotnik KL et al. Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the UCLA family study. Arch. Gen. Psychiatry59, 1053–1060 (2002).
   PubMed Web of Science ®Google Scholar
• Toomey R, Faraone SV, Seidman LJ, Kremen WS, Pepple JR, Tsuang MT. Association of vulnerability markers in relatives of schizophrenic patients. Schizophr. Res.31, 89–98 (1998).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Kremen WS, Lyons MJ, Pepple JR, Seidman LJ, Tsuang MT. Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes? Am. J. Psychiatry152, 1286–1290 (1995).
   PubMed Web of Science ®Google Scholar
• Kremen WS, Lyons MJ, Boake C et al. A discordant twin study of premorbid cognitive ability in schizophrenia. J. Clin. Exp. Neuropsychol.28(2), 208–224 (2006).
   PubMed Web of Science ®Google Scholar
• Mrazek P, Haggerty R. Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research. National Academy of Sciences, Institute of Medicine, DC, USA (1994).
   Google Scholar
• Gottesman II, Shields J. Schizophrenia and Genetics: A Twin Study Vantage Point. Academic Press, NY, USA (1972).
   Google Scholar
• Meehl PE. Schizotaxia, schizotypy, schizophrenia. Am. Psychol.17, 827–838 (1962).
   Web of Science ®Google Scholar
• Meehl PE. Schizotaxia revisited. Arch. Gen. Psychiatry46, 935–944 (1989).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Green AI, Seidman LJ, Tsuang MT. ‘Schizotaxia’: clinical implications and new directions for research. Schizophr. Bull.27, 1–18 (2001).
   PubMed Web of Science ®Google Scholar
• Tsuang MT, Stone WS, Seidman LJ et al. Treatment of nonpsychotic relatives of patients with schizophrenia: four case studies. Biol. Psychiatry41, 1412–1418 (1999).
   Google Scholar
• Tsuang MT, Stone WS, Tarbox SI, Faraone SV. An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention. Schizophr. Res.54(1–2), 169–175 (2002).
   PubMed Web of Science ®Google Scholar
• Stone WS, Faraone SV, Seidman LJ, Green AI, Wojcik JD, Tsuang MT. Concurrent validation of schizotaxia: a pilot study. Biol. Psychiatry50(6), 434–440 (2001).
   PubMed Web of Science ®Google Scholar
• Simon AE, Roth B, Zmilacher S, Isler E, Umbricht D. Developing services for the early detection of psychosis: a critical consideration of the current state of the art. Eur. Child Adolesc. Psychiatry16(2), 96–103 (2007).
   PubMed Web of Science ®Google Scholar
• Simon AE, Lester H, Tait L et al. The International Study on General Practitioners and Early Psychosis (IGPS). Schizophr. Res.108(1–3), 182–190 (2009).
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Phillips LJ. The “close-in” or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr. Bull.29(4), 771–790 (2003).
   PubMed Web of Science ®Google Scholar
• Phillips LJ, Yung AR, Yuen HP, Pantelis C, McGorry PD. Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. Am. J. Med. Genet.114(8), 929–937 (2002).
   PubMed Web of Science ®Google Scholar
• Yung AR, Phillips LJ, Yuen HP et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr. Res.60(1), 21–32 (2003).
   PubMed Web of Science ®Google Scholar
• Cannon TD, Cadenhead KS, Cornblatt B et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry65, 28–37 (2008).
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Zipursky RB, Perkins D et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr. Res.61(1), 7–18 (2003).
   PubMed Web of Science ®Google Scholar
• Ruhrmann S, Schultze-Lutter F, Klosterkotter J. Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry36(Suppl. 3), S162–S167 (2003).
   PubMed Web of Science ®Google Scholar
• Simon AE, Roth B, Zmilacher S, Isler E, Umbricht D. Developing services for the early detection of psychosis: a critical consideration of the current state of the art. Eur. Child Adolesc. Psychiatry16, 96–103 (2007).
   PubMed Web of Science ®Google Scholar
• McGorry PD, Killackey EJ. Early intervention in psychosis: a new evidence based paradigm. Epidemiol. Psichiatr. Soc.11(4), 237–247 (2002).
   PubMedGoogle Scholar
• Walker EF, Cornblatt B, Addington J et al. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophr. Res.115, 50–57 (2009).
   PubMed Web of Science ®Google Scholar
• Simon AE, Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res.116, 168–172 (2010).
   PubMed Web of Science ®Google Scholar
• Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am. J. Psychiatry149(9), 1183–1188 (1999).
   Google Scholar
• Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta analysis. Am. J. Psychiatry162, 1785–1804 (2005).
   PubMed Web of Science ®Google Scholar
• Farooq S, Large M, Nielssen O, Waheed W. The relationship between the duration of untreated psychosis and outcome in low-and-middle income countries: a systematic review and meta analysis. Schizophr. Res.109, 15–23 (2009).
   PubMed Web of Science ®Google Scholar
• Friis S, Vaglum P, Haahr U et al. Effect of an early detection programme on duration of untreated psychosis: part of the Scandinavian TIPS study. Br. J. Psychiatry Suppl.48, S29–S32 (2005).
   Google Scholar
• Johannessen JO, Larsen TK, Joa I et al. Pathways to care for first-episode psychosis in an early detection healthcare sector: part of the Scandinavian TIPS study. Br. J. Psychiatry Suppl.48, S24–S28 (2005).
   Google Scholar